We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 19th, 2023 • Alpha Teknova, Inc. • In vitro & in vivo diagnostic substances • California
Contract Type FiledSeptember 19th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 15, 2023, between Alpha Teknova, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 19th, 2021 • Ancora Advisors, LLC • Retail-eating places • New York
Contract Type FiledFebruary 19th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of February 9, 2021, between Potbelly Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 2nd, 2009 • Catalyst Pharmaceutical Partners, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 2nd, 2009 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 1, 2009, between Catalyst Pharmaceutical Partners, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 18th, 2006 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledDecember 18th, 2006 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of December 15, 2006, by and among RegeneRx Biopharmaceuticals, Inc, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).